High risk cytogenetic abnormalities in patients with multiple myeloma

被引:3
作者
Eugenia Legues, Maria [1 ,2 ]
Morales, Paulina [1 ]
Valenzuela, Mercedes [1 ]
Encina, Andrea [1 ]
Jose Marti, Maria [1 ]
Bascunan, Claudia [1 ]
Cornejo, Paulina [1 ]
Pena, Camila [3 ]
Soledad Undurraga, Maria [1 ]
机构
[1] Hosp Salvador, Secc Hematol, Lab Citogenet, Santiago, Chile
[2] Univ Chile, Dept Med Interna Oriente, Av Salvador 486 1er Piso, Santiago, Chile
[3] Hosp Salvador, Unidad Hematol Clin, Santiago, Chile
关键词
Chromosome Aberrations; Cytogenetics; Multiple Myeloma;
D O I
10.4067/S0034-98872019000100061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cytogenetic abnormalities observed in the bone marrow of patients with multiple myeloma (MM) are an important prognostic factor for risk stratification. Aim: To investigate karyotype characteristics and frequency of the high-risk cytogenetic abnormalities t(4;14), t( 14;16) and del(17p) in Chilean patients with MM. Material and Methods: We studied 30 patients with MM by conventional cytogenetics (CC) and fluorescent in situ hybridization of plasma cells selected using cytoplasmic immunoglobulin staining (cIg-FISH). Results: Overall, the two techniques in combination allowed us to identify clonal genetic abnormalities in 47% of patients. The t(4;14) abnormality was observed in 19% of patients, del( 17p) was observed in 10% of patients, and t(14;16) was not detected. Conclusions: Our results showed frequencies of high-risk abnormalities similar to those reported abroad. Cytogenetic studies should be performed routinely for all MM patients at the moment of diagnosis.
引用
收藏
页码:61 / 64
页数:4
相关论文
共 9 条
[1]   The Impact of Clone Size on the Prognostic Value of Chromosome Aberrations by Fluorescence In Situ Hybridization in Multiple Myeloma [J].
An, Gang ;
Li, Zengjun ;
Tai, Yu-Tzu ;
Acharya, Chirag ;
Li, Qian ;
Qin, Xiaoqi ;
Yi, Shuhua ;
Xu, Yan ;
Feng, Xiaoyan ;
Li, Chengwen ;
Zhao, Jiawei ;
Shi, Lihui ;
Zang, Meirong ;
Deng, Shuhui ;
Sui, Weiwei ;
Hao, Mu ;
Zou, Dehui ;
Zhao, Yaozhong ;
Qi, Junyuan ;
Cheng, Tao ;
Ru, Kun ;
Wang, Jianxiang ;
Anderson, Kenneth C. ;
Qiu, Lugui .
CLINICAL CANCER RESEARCH, 2015, 21 (09) :2148-2156
[2]   Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma [J].
Bergsagel, P. Leif ;
Mateos, Maria-Victoria ;
Gutierrez, Norma C. ;
Rajkumar, S. Vincent ;
Miguel, Jesus F. San .
BLOOD, 2013, 121 (06) :884-892
[3]   International Myeloma Working Group molecular classification of multiple myeloma: spotlight review [J].
Fonseca, R. ;
Bergsagel, P. L. ;
Drach, J. ;
Shaughnessy, J. ;
Gutierrez, N. ;
Stewart, A. K. ;
Morgan, G. ;
Van Ness, B. ;
Chesi, M. ;
Minvielle, S. ;
Neri, A. ;
Barlogie, B. ;
Kuehl, W. M. ;
Liebisch, P. ;
Davies, F. ;
Chen-Kiang, S. ;
Durie, B. G. M. ;
Carrasco, R. ;
Sezer, Orhan ;
Reiman, Tony ;
Pilarski, Linda ;
Avet-Loiseau, H. .
LEUKEMIA, 2009, 23 (12) :2210-2221
[4]   Observational study of multiple myeloma in Latin America [J].
Hungria, Vania T. M. ;
Maiolino, Angelo ;
Martinez, Gracia ;
Duarte, Gislaine Oliveira ;
Bittencourt, Rosane ;
Peters, Lygia ;
Colleoni, Gisele ;
Oliveira, Luciana C. O. ;
Crusoe, Edvan ;
Coelho, Erika O. D. M. ;
Pasquini, Ricardo ;
Magalhes, Silvia M. M. ;
Nunes, Renata ;
Pinto Neto, Jorge V. ;
Faria, Rosa Malena O. ;
Souza, Mair ;
Hamerschlak, Nelson ;
Flantl, Dorotea ;
Navarro, J. R. ;
Conte, Guillermo ;
Gomez-Almaguer, David ;
Ruiz-Arguelles, Guillermo ;
Durie, Brian G. M. .
ANNALS OF HEMATOLOGY, 2017, 96 (01) :65-72
[5]   Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients [J].
Kumar, S. K. ;
Dispenzieri, A. ;
Lacy, M. Q. ;
Gertz, M. A. ;
Buadi, F. K. ;
Pandey, S. ;
Kapoor, P. ;
Dingli, D. ;
Hayman, S. R. ;
Leung, N. ;
Lust, J. ;
McCurdy, A. ;
Russell, S. J. ;
Zeldenrust, S. R. ;
Kyle, R. A. ;
Rajkumar, S. V. .
LEUKEMIA, 2014, 28 (05) :1122-1128
[6]   Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group [J].
Palumbo, Antonio ;
Avet-Loiseau, Herve ;
Oliva, Stefania ;
Lokhorst, Henk M. ;
Goldschmidt, Hartmut ;
Rosinol, Laura ;
Richardson, Paul ;
Caltagirone, Simona ;
Jose Lahuerta, Juan ;
Facon, Thierry ;
Bringhen, Sara ;
Gay, Francesca ;
Attal, Michel ;
Passera, Roberto ;
Spencer, Andrew ;
Offidani, Massimo ;
Kumar, Shaji ;
Musto, Pellegrino ;
Lonial, Sagar ;
Petrucci, Maria T. ;
Orlowski, Robert Z. ;
Zamagni, Elena ;
Morgan, Gareth ;
Dimopoulos, Meletios A. ;
Durie, Brian G. M. ;
Anderson, Kenneth C. ;
Sonneveld, Pieter ;
San Miguel, Jesus ;
Cavo, Michele ;
Rajkumar, S. Vincent ;
Moreau, Philippe .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (26) :2863-+
[7]   Interphase Fluorescence In Situ Hybridization on Selected Plasma Cells is Superior in the Detection of Cytogenetic Aberrations in Plasma Cell Dyscrasia [J].
Put, Natalie ;
Lemmens, Heidi ;
Wlodarska, Iwona ;
Konings, Peter ;
Moreau, Yves ;
Hagemeijer, Anne ;
Vandenberghe, Peter ;
Michaux, Lucienne .
GENES CHROMOSOMES & CANCER, 2010, 49 (11) :991-997
[8]   Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders [J].
Ross, Fiona M. ;
Avet-Loiseau, Herve ;
Ameye, Genevieve ;
Gutierrez, Norma C. ;
Liebisch, Peter ;
O'Connor, Sheila ;
Dalva, Klara ;
Fabris, Sonia ;
Testi, Adele M. ;
Jarosova, Marie ;
Hodkinson, Clare ;
Collin, Anna ;
Kerndrup, Gitte ;
Kuglik, Petr ;
Ladon, Dariusz ;
Bernasconi, Paolo ;
Maes, Brigitte ;
Zemanova, Zuzana ;
Michalova, Kyra ;
Michau, Lucienne ;
Neben, Kai ;
Hermansen, N. Emil U. ;
Rack, Katrina ;
Rocci, Alberto ;
Protheroe, Rebecca ;
Chiecchio, Laura ;
Poirel, Helene A. ;
Sonneveld, Pieter ;
Nyegaard, Mette ;
Johnsen, Hans E. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08) :1272-1277
[9]   The prognostic significance of cytogenetics and molecular profiling in multiple myeloma [J].
Sawyer, Jeffrey R. .
CANCER GENETICS, 2011, 204 (01) :3-12